Mizuho Financial Group Inc. Sponosred ADR (Japan) vs 10X Genomics Inc — how do they compare? Mizuho Financial Group Inc. Sponosred ADR (Japan) trades at $10.59 (market cap $127.85B), while 10X Genomics Inc trades at $82.4 (market cap $10.07B). The key difference: Mizuho Financial Group Inc. Sponosred ADR (Japan) is far larger — about 12.7× 10X Genomics Inc's market cap, and Mizuho Financial Group Inc. Sponosred ADR (Japan) pays a 1.72% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Mizuho Financial Group Inc. Sponosred ADR (Japan) for 1 Days and 10X Genomics Inc for 92 Days on average.
| MFG | TXG | |
|---|---|---|
Market Cap | $127.85B | $10.07B |
Volume | 3,950,750 | 5,657,286 |
Sector | Financials | Health |
52-Week High | $11.45 | $97.74 |
52-Week Low | $6.09 | $11.48 |
Typical Hold Time | 1 Days | 92 Days |
Enterprise Value | $35.14T | $9.59B |
Dividend Yield | 1.72% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
10x Genomics (TXG) trades at $82.37, up 8.24% over 24 hours, with a bearish technical signal and mixed analyst sentiment. The company reported a net loss of $43.54M in 2025, but revenue grew to $642.82M, and it has beaten EPS estimates for three consecutive quarters. Recent news highlights strong demand for its Atera platform and a patent victory, though profitability remains a challenge.
The outlook is cautiously optimistic, with growth potential from new product launches and spatial biology demand, but risks include persistent losses, high valuation multiples, and competitive pressures. The consensus price target is $74.30, below the current price, suggesting limited near-term upside.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Mizuho Financial Group is a Japanese financial services company offering banking, trust, securities, and asset management services. It serves retail, corporate, and institutional clients globally.
Read more on MFG →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →